LOCALLY ADVANCED ESOPHAGEAL ADENOCARCINOMA
Clinical trials for LOCALLY ADVANCED ESOPHAGEAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED ESOPHAGEAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED ESOPHAGEAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to fight Hard-to-Treat stomach cancers
Disease control Not yet recruitingThis early-phase trial tests whether adding the experimental drug futibatinib to standard chemotherapy (paclitaxel) and an antibody (ramucirumab) is safe for people with advanced stomach, gastroesophageal junction, or esophageal cancer that cannot be removed by surgery. The study…
Matched conditions: LOCALLY ADVANCED ESOPHAGEAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New hope for esophageal cancer patients after first treatment fails
Disease control Not yet recruitingThis phase 2 trial tests whether a combination of two immunotherapy drugs (Iparomlimab and Tuvonralimab) plus chemoradiotherapy can help people with locally advanced esophageal cancer whose initial chemo-immunotherapy did not work. About 40 participants will receive the treatment…
Matched conditions: LOCALLY ADVANCED ESOPHAGEAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC